Adamyan v. Pfizer

|

(U.S., filed July 26, 2019): Arguing that sua sponte orders by state courts consolidating the claims of 100 or more plaintiffs support removal under the mass action provision of the Class Action Fairness Act of 2005.

Case not yet decided

Latest News

View all news

SCOTUS Should Affirm Federal Law Supremacy With FDA Authority Case

The U.S. Supreme Court has a chance to rein in state court rulings that impose liability on pharmaceutical companies that go beyond, and even contradict, the federal regulatory process of the FDA, according to Tiger Joyce, president of the American Tort Reform Association. He explains why it is imperative the high court review a case involving Janssen Pharmaceuticals.